Physician profile
Kevin Johnson
NPI 1538246855
$4,739.62
in general payments reported to CMS, 2019-2025
12 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.12 · 2020: $68.75 · 2021: $815 · 2022: $774 · 2023: $452 · 2024: $2,299 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $849 · Debt Forgiveness: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $849.47 |
| Debt Forgiveness | $196.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,201.85 | 2023-2025 | Precision 1, Air Optix Color, Dailies Total1 |
| Coopervision INC. | $1,613.76 | 2019-2024 | Myday Contact Lens |
| Optos, INC. | $196.90 | 2023 | Panoramic Ophthalmoscope |
| Allergan, INC. | $131.22 | 2021 | |
| Bausch & Lomb Americas INC. | $125.00 | 2025 | Infuse Multifocal |
| Oyster Point Pharma, INC. | $122.82 | 2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $105.08 | 2024 | |
| Aerie Pharmaceuticals, INC. | $84.15 | 2021 | |
| Abb Con-Cise Optical Group LLC | $68.75 | 2020 | |
| Abbvie INC. | $42.36 | 2022 | |
| Abiomed | $30.37 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $17.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.